Skip to main content
SpringerLink
Log in

Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?

  • Practice Point
  • Published:

From Nature Clinical Practice Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ferenci P et al. (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 35: 716–721

    Article  Google Scholar 

  2. Strauss E and da Costa MF (1998) The importance of bacterial infections as precipitating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 45: 900–904

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Consultant Hepatologist and Professor of Medicine Case Western Reserve School of Medicine, OH, USA

    Kevin D Mullen

  2. Gastroenterology Fellow, at Case Western Reserve School of Medicine, OH, USA

    Randy Howard

Authors
  1. Kevin D Mullen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Randy Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin D Mullen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullen, K., Howard, R. Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?. Nat Rev Gastroenterol Hepatol 2, 264–265 (2005). https://doi.org/10.1038/ncpgasthep0194

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0194

  • Springer Nature Limited

This article is cited by

Search

Navigation